Eupraxia Pharmaceuticals (EPRX) Return on Assets [ROA] (2024 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Return on Assets [ROA] of -39.67% for Q2 2026, up 64.26 percentage points from -103.93% a year earlier and up 0.91 percentage points from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Return on Assets [ROA] (2024 - 2026) Analysis & Trends
For FY2025, Eupraxia Pharmaceuticals posted Return on Assets [ROA] of -63.76%, up 29.50 percentage points from FY2024.
- By year, Return on Assets [ROA] came in at -93.26% in FY2024 (+53.82 pp) and -147.08% in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] in data going back to Q1 2024.
- Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of +50.88 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -40.58% (Q1 2026), -43.26% (Q4 2025) and -49.10% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | -47.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -47.11% |
| Jun 30, 2026 | -39.67% |
| Mar 31, 2026 | -40.58% |
| Dec 31, 2025 | -43.26% |
| Sep 30, 2025 | -49.10% |
| Jun 30, 2025 | -103.93% |
| Mar 31, 2025 | -81.91% |
| Dec 31, 2024 | -113.64% |
| Sep 30, 2024 | -163.99% |
| Jun 30, 2024 | -90.62% |
| Mar 31, 2024 | -109.64% |
API Access
Eupraxia Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();